Tiffany A. Katz

Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells

Shauna N. Vasilatos, Tiffany A. Katz, Steffi Oesterreich et al. · Carcinogenesis · 2013 · 114 citations · Full text

Medicine, Oncology, Pharmacology +16

The NIEHS TaRGET II Consortium and environmental epigenomics

Ting Wang, Erica C. Pehrsson, Deepak Purushotham et al. · Nature Biotechnology · 2018 · 110 citations

Life Sciences, Environmental Sciences, Genetics +14

Loss of E-cadherin Enhances IGF1–IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors

Alison M. Nagle, Kevin M. Levine, Nilgun Tasdemir et al. · Clinical Cancer Research · 2018 · 86 citations

Medicine, Cancer Biology, Oncology +17

Epigenome environment interactions accelerate epigenomic aging and unlock metabolically restricted epigenetic reprogramming in adulthood

Lindsey S. Treviño, Jianrong Dong, Ahkilesh Kaushal et al. · Nature Communications · 2020 · 61 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells

Tiffany A. Katz, Shauna N. Vasilatos, Emily Harrington et al. · Breast Cancer Research and Treatment · 2014 · 59 citations

Life Sciences, Genetics, Molecular Biology +17